Berman Capital Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $15K | Hold |
566
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q2 | $16K | Buy |
566
+17
| +3% | +$481 | ﹤0.01% | 994 |
|
|
2021
Q1 | $15K | Sell |
549
-14
| -2% | -$383 | ﹤0.01% | 908 |
|
|
2020
Q4 | $15K | Hold |
563
| – | – | ﹤0.01% | 771 |
|
|
2020
Q3 | $14K | Hold |
563
| – | – | ﹤0.01% | 702 |
|
|
2020
Q2 | $13K | Buy |
563
+92
| +20% | +$2.12K | ﹤0.01% | 680 |
|
|
2020
Q1 | $6K | Hold |
471
| – | – | ﹤0.01% | 860 |
|
|
2019
Q4 | $7K | Hold |
471
| – | – | ﹤0.01% | 894 |
|
|
2019
Q3 | $6K | Buy |
+471
| New | +$6K | ﹤0.01% | 914 |
|